The Dalai Lama always stirs up plenty of karmic excitement when he comes to town. But a sold-out conference--"Investigating the Mind: Exchanges Between Buddhism and the Biobehavioral Sciences on How the Mind Works"--held last week at the Massachusetts Institute of Technology had a bunch of Western scientists downright giddy.
There is Hollywood's too-perfect version of mental illness--"Ordinary People," "Rain Man," "A Beautiful Mind." And then there's the raw stuff of "West 47th Street," a documentary airing this week and next on public-television stations nation-wide (check local listings at pbs.org/pov/pov2003/west47thstreet).
Eating disorders are generally thought of as a plague of affluent white girls, but minorities aren't immune. In a study of just over 2,000 women (average age: 21) published in The American Journal of Psychiatry last week, Ruth Striegel-Moore of Wesleyan University found that whites were more likely than blacks to suffer from bulimia (23 cases to 4) and anorexia (15 to 0).
First, there's the brilliant idea: figure out a way to inhale insulin, so diabetics can ditch the dreaded needle. But then comes the long slog to market. For John Patton, cofounder and chief scientific officer of Nektar Therapeutics in San Carlos, Calif.--and a pioneer in the technology known as pulmonary or inhaled-drug delivery--the journey began in 1990.
It's not pretty out there. Last week a fourth cruise ship departing a U.S. port since October reported vomiting and diarrhea among passengers and crew. And a ship that had been cleaned after an initial outbreak, Carnival's Fascination, returned to land on Friday with a small new batch of victims.